Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
HIV Prevention Cuts Medical Costs

Averting a single infection could save up to $338,000 over a lifetime.

Published
27 February 2015
From
MedPage Today HIV/AIDS
Treatment cascades and viral load surveys show how African countries can maximise prevention benefits of HIV treatment

Reaching ambitious HIV prevention targets in South Africa will require intensified efforts to engage and retain men and young people in care, in order to increase the

Published
27 February 2015
By
Keith Alcorn
US PEPFAR abstinence and faithfulness funding had no impact on sexual behaviour in Africa

Nearly US$1.3 billion spent on US-funded programmes to promote abstinence and faithfulness in sub-Saharan Africa had no significant impact on sexual behaviour in 14 countries in sub-Saharan

Published
26 February 2015
By
Keith Alcorn
CROI 2015: Trial to evaluate the use of health navigators to link HIV/TB patients to care and treatment fails to show positive results

Patients randomized to the support of a health navigator were not more likely than those who received standard of care to complete tuberculosis treatment or begin antiretroviral therapy within three months of HIV diagnosis, according to the results of a South African randomized trial presented here today.

Published
26 February 2015
From
Science Speaks
HIV and LGTB NGOs and other concerned actors across Europe call for futher action on pre-exposure prophylaxis

The European AIDS Treatment Group (EATG), Europe’s network of HIV activists, and  AIDES, a leading French NGO in the fight against AIDS and viral hepatitis, backed by 81 European HIV LGBT civil society organisations and concerned actors, issued an urgent HIV Prevention Manifesto today. We demand that pre-exposure prophylaxis for HIV (PrEP) is made available as soon as possible within the European Union, and that Gilead, the company that makes the PrEP medicine Truvada®, submits an application to the European Medicines Agency (EMA) for a change of indication so that its use to prevent HIV can be approved.

Published
25 February 2015
From
EATG
'Give HIV drugs to healthy gay men'

Healthy gay men should be offered daily HIV drugs to prevent infections, say UK Medical Research Council and Public Health England scientists. Their study, on 545 high-risk men, found one case of HIV could be stopped for every 13 men treated for a year. The research team says it would be similar to the pill for women and would not encourage risky sex. The findings have been described as a "game changer" and the NHS is considering how to adopt them.

Published
25 February 2015
From
BBC News
Pre-exposure prophylaxis (PrEP) stops 86% of HIV infections in PROUD study

A study of pre-exposure prophylaxis (PrEP), the English PROUD study, demonstrated the highest effectiveness yet seen for this method of HIV prevention, the Conference on Retroviruses and

Published
24 February 2015
By
Gus Cairns
Local spending on HIV prevention in England plunges to 70p per person, per year

HIV prevention in England is underfunded and deprioritised, says the National AIDS Trust (NAT). Whereas £55 million was allocated to local activities in 2001-02, the figure for

Published
24 February 2015
By
Roger Pebody
Merck places children's HIV drug in shared non-profit patent pool

U.S. drugmaker Merck & Co has contributed an HIV medicine for children to an international shared patent pool in a move that should speed the development of cheap pediatric formulations for use in poor countries.

Published
24 February 2015
From
Reuters
Critiquing UNAIDS HIV Prevention Goals, AVAC Calls For Honed Strategy

The global HIV advocacy group AVAC has raised an alarm that global goals for HIV prevention may prove ineffectual due to their vagueness.

Published
24 February 2015
From
AIDSMeds

Filter by country